[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diphtheria Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 70 pages | ID: D2EDCFBC86D7EN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Diphtheria Drug pipeline report- 2020 is an annual R&D review of Diphtheria pipeline candidates. The report presents the current status of all major Diphtheria therapeutic compounds. Detailed insights into Diphtheria pipeline development, current status, companies, drug profiles and Diphtheria preclinical and clinical trials are included.

2020 Diphtheria Pipeline Market Insights
Diphtheria disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Diphtheria therapies, pipeline by phase and others are included.

Diphtheria pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Diphtheria Therapeutic Drug candidates
Both active and inactive Diphtheria pipeline drug candidates are included in the report

Diphtheria Clinical Trials and preclinical Studies
Diphtheria In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Diphtheria pipeline market developments
Diphtheria Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Diphtheria pipeline companies in active development
The report analyzes Diphtheria pipeline of the below companies-

Beijing Minhai Biotechnology Co Ltd, BIKEN Corp, Boryung Pharmaceutical Co Ltd, Cadila Healthcare Ltd, GC Pharma, GlaxoSmithKline Plc, Indian Immunologicals Ltd, LG Chem Ltd, MassBiologics, Olymvax Biopharmaceuticals Inc, Panacea Biotec Ltd, Sanofi, Sanofi Pasteur SA, Serum Institute of India Ltd, Shantha Biotechnics Pvt Ltd, Tianjin CanSino Biotechnology Inc, Wockhardt Ltd

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
17 Companies investing in Diphtheria pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Diphtheria pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. DIPHTHERIA PIPELINE MARKET INSIGHTS, 2020

1.1 Diphtheria Disease Overview
1.2 Diphtheria Drug Pipeline Snapshot, 2020
  1.2.1 Diphtheria Pipeline Drugs by Phase
  1.2.2 Diphtheria Pipeline Drugs by Company
  1.2.3 Diphtheria Pipeline Drugs by Mechanism of Action
  1.2.4 Diphtheria Pipeline Drugs by Route of Administration

2. DIPHTHERIA COMPANY WISE PIPELINE DETAILS

Beijing Minhai Biotechnology Co Ltd Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
BIKEN Corp Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Boryung Pharmaceutical Co Ltd Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cadila Healthcare Ltd Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
GC Pharma Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Indian Immunologicals Ltd Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
LG Chem Ltd Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
MassBiologics Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Olymvax Biopharmaceuticals Inc Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Panacea Biotec Ltd Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi Pasteur SA Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Serum Institute of India Ltd Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Shantha Biotechnics Pvt Ltd Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tianjin CanSino Biotechnology Inc Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details
Wockhardt Ltd Diphtheria Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. DIPHTHERIA DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. DIPHTHERIA PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications